Invasive fungal diseases during COVID-19: We should be prepared

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet RespirMed, 10.1016/S2213-2600(20)30079-5

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Schauwvlieghe, 2018, Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study, Lancet Respir Med, 6, 782, 10.1016/S2213-2600(18)30274-1

Verweij, 2020, Influenza coinfection : Be(a)ware of invasive aspergillosis, Clin Infect Dis, 70, 349, 10.1093/cid/ciz391

van de Veerdonk, 2017, Influenza-associated aspergillosis in critically ill patients, Am J Respir Crit Care Med, 196, 524, 10.1164/rccm.201612-2540LE

He, 2020, Coronavirus disease 2019 (COVID-19): what we know?, J Med Virol, 14

Chen, 2020, Clinical and immunologic features in severe and moderate Coronavirus disease 2019, J Clin Invest, 137244

Bitar, 2014, Population-based analysis of invasive fungal infections, France, 2001–2010, Emerg Infect Dis, 20, 1149, 10.3201/eid2007.140087

Gangneux, 2016, LIFE program, the Société française de mycologie médicale SFMM-study group. An estimation of burden of serious fungal infections in France, J Mycol Med, 26, 385, 10.1016/j.mycmed.2016.11.001

Haut Conseil de la santé publique, 2020

Lescure, 2020, Clinical and virological data of the first cases of COVID-19 in Europe: a case series, Lancet Infect Dis, 27